February 2023 Newsletter
ASBM and GaBI Spring Webinar Series to Examine Inflation Reduction Act In April and May, ASBM and the Generics and Biosimilars Initiative (GaBI) will host two new webinars examining the implications of the recently-passed Inflation Reduction Act (IRA). The webinars will focus on the unintended consequences that may result from the implementation of IRA […]